B
MRTX

Braslyn’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Braslyn’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,135,966
Closed -$184M – 3
2023
Q4 		$184M Buy
+3,135,966
New +$184M 98.96% 1